Real-World Study of Everolimus in Advanced Progressive Neuroendocrine TumorsFrancesco Panzuto, Gianfranco Delle Fave, Maria Rinzivillo et al.|The Oncologist|2014Cited by 103
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizationsFrancesco Panzuto, Davide Campana, Sara Pusceddu et al.|Pancreatology|2019Cited by 27
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national databaseFrancesco Panzuto, Massimo Falconi, Stefano Partelli et al.|Endocrine|2024Cited by 19
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine TumorsFrancesco Panzuto, Gianfranco Delle Fave, Maria Rinzivillo et al.|The Oncologist|2015Cited by 9
Impact of dyslipidemia and lipid‐lowering therapy with statins in patients with neuroendocrine tumorsAntongiulio Faggiano, Annamaria Colao, Rossella Mazzilli et al.|Journal of Neuroendocrinology|2024Cited by 4